Furthermore, when we repeated the meta-analysis excluding ELIXA, the trial done with a short-acting GLP-1 receptor agonist in patients with acute coronary syndrome, the outcome of worsening of kidney function, based predominantly on change in eGFR, was also improved. Sattar and colleagues analyzed data from eight randomized, placebo-controlled trials with 60,080 participants testing injectable or oral GLP-1 receptor agonists in adults with type 2 diabetes, including the recently presented AMPLITUDE-O
Practical Considerations for Clinicians For healthcare providers at LifeRx.md and beyond, incorporating GLP-1 receptor agonists into treatment plans for obese patients requires careful patient selection and monitoring
Beyond tactics, they explore the vital mindset shifts required in entrepreneurship: adopting an abundance mentality, building resilience and persistence, and prioritizing well-being for long-term sustainability
As the gut adapts post-GLP-1 therapy, supporting microbial diversity and barrier integrity becomes paramount